GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Capital Expenditure

Runben Biotechnology Co (SHSE:603193) Capital Expenditure : ¥-83.52 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Runben Biotechnology Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Runben Biotechnology Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-11 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-83.52 Mil.

Runben Biotechnology Co Capital Expenditure Historical Data

The historical data trend for Runben Biotechnology Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Runben Biotechnology Co Capital Expenditure Chart

Runben Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial -58.21 -152.03 -40.65 -13.65 -74.23

Runben Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.97 -6.23 -37.09 -28.94 -11.27

Runben Biotechnology Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-83.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Runben Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Capital Expenditure
Comparable Companies
SHSE:603868 SHSE:600315 SZSE:003006 SHSE:603983 SZSE:301371 SZSE:300957 SZSE:002511 SHSE:605009 SZSE:001328 SZSE:000523 PG XPAR:OR LSE:ULVR CL BOM:500696 KVUE KMB LSE:RKT XTER:HEN3 XTER:BEI
Traded in Other Exchanges
N/A
Address
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627
Website
https://www.runben.com
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.

Runben Biotechnology Co Headlines

No Headlines